4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-24-000032
Options or other derivatives
- Chief Business Officer acquired 115,000 shares (grant or award)
- Chief Business Officer returned 115,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Boyle Scott N · Chief Business Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-07 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −115,000 | 0 | D |
| 2024-03-07 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +115,000 | 115,000 | D |
Loading xslF345X05/wk-form4_1709944127.xml…